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Acetylcholinesterase (AChE) in the serum of fetal cow is a tetramer. The related enzyme, butyrylcholinesterase
(BChE), in the sera of humans and horse requires polyproline peptides for assembly into tetramers. Our goal
was to determine whether soluble tetrameric AChE includes tetramer organizing peptides in its structure.
Fetal bovine serum AChE was denatured by boiling to release non-covalently bound peptides. Bulk protein
was separated from peptides by filtration and by high performance liquid chromatography. Peptide mass and
amino acid sequence of the released peptides were determined by MALDI–TOF–TOF and LTQ-Orbitrap mass
spectrometry. Twenty polyproline peptides, divided into 5 families, were identified. The longest peptide
contained 25 consecutive prolines and no other amino acid. Other polyproline peptides included one non-
proline amino acid, for example serine at the C-terminus of 20 prolines. A search of the mammalian proteome
database suggested that this assortment of polyproline peptides originated from at least 5 different precursor
proteins, none of which were the ColQ or PRiMA of membrane-anchored AChE. To date, AChE and BChE are
the only proteins known that include polyproline tetramer organizing peptides in their tetrameric structure.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
Vertebrate acetylcholinesterase (AChE; EC 3.1.1.7) belongs to the
serine-esterase protein family [1]. AChE terminates the action of
acetylcholine at the post-synaptic membrane in the neuromuscular
junction. AChE is also found in a variety of other tissues where its func-
tion is unclear. For example, AChE is abundant in fetal bovine serum, but
not in the serum of the adult cowwhere its concentration is only 10% of
that in fetal serum [2]. In the neuromuscular junction, tetrameric forms
of AChE are anchored to the basal lamina via a collagenous subunit re-
ferred to as ColQ [3]. In the brain, tetrameric forms of AChE are bound
to membranes via a proline-rich membrane anchor (PRiMA) [4]. Both
ColQ and PRiMA contain a proline-rich domain (PRAD) that is credited
with organizing AChE monomers into tetramers. The crystal structure
of the 40-residue AChE tetramerization domain in complex with the
15-residue PRAD peptide shows four highly conserved tryptophan
amphiphilic α-helices from the C-terminus of AChE wrapped around
an antiparallel left-handed PRAD helix resembling polyproline II [5].
The essential feature of PRAD is the presence of long stretches of consec-
utive proline residues. Even synthetic polyproline can function to orga-
nize AChE monomers into tetramers [6].
AChE can also be found in soluble form. Co-expression of AChE with
the proline-rich fragment from ColQ promotes secretion of stable AChE
tetramers in cell culture. In the absence of the proline-rich fragment,
only monomers and dimers are secreted, indicating that the proline-
rich fragment organizes assembly of the soluble tetramer [7]. It was
found that soluble, tetrameric butyrylcholinesterase in human serum
is stabilized by a proline-rich peptides derived from the lamellipodin
protein [8] in addition to several other proteins. This strongly suggests
that the tetramer-organizing peptides used for soluble cholinesterases
are different from those employed by membrane-bound forms, but
also suggests that they share a common polyproline motif. However,
the identity of the proline-rich peptides present in naturally-occurring,
soluble AChE has not been determined.
Fetal bovine serum (FBS) is a particularly rich source of soluble
AChE. FBS AChE is a symmetric tetrameric globule with a molecular
mass of 340,000 Da. The four subunits are associated in a dimer-of-
dimers motif. That is, two pairs of disulfide crosslinked monomers
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are held together by hydrophobic interactions [9]. Based on the fore-
going discussion it is to be expected that the tetrameric assembly of
FBS AChE is organized around a proline-rich peptide.
In the present study, we extracted and characterized the
polyproline peptides of FBS AChE. The protein was denatured by boil-
ing to release the peptides. Released peptides, separated from AChE
subunits by HPLC or by filtration, were analyzed by mass spectrome-
try. We identified polyproline-rich peptides none of which matched
the PRAD sequence from either ColQ or PRiMA.
2. Methods and materials
2.1. Materials
AChE from fetal bovine serum was purified from serum pooled from
multiple animals as described [10] and stored at−80 °C in 50% glycerol
until use. The FBS AChE was 99% pure as determined by Coomassie blue
staining of an SDS gel and confirmed bymeasurement of specific activity.
α-Cyano-4-hydroxy cinnamic acid (α-CHCA, catalog number 70990)
from Fluka (a member of the Sigma-Aldrich group, St. Louis, MO) was
prepared as a saturated solution (10 mg/ml) in 50% acetonitrile/water
plus 0.3% trifluoroacetic acid. Acetonitrile was of DNA sequencing
grade from Fisher (Pittsburgh, PA, catalog number BP-1170), and
trifluoroacetic acid was of sequencing grade (>99.9%) from Beckman
(Brea, CA, catalog number 290204). 5,5′-dithiobis-(2-nitrobenzoic
acid) was from Sigma-Aldrich (catalog number D8130). Formic acid
(puriss p.a. for mass spectrometry, catalog number 94318) was from
Sigma-Aldrich. All other chemicals were of biochemical grade.
2.2. AChE activity
Activity was assayed with 1 mM acetylthiocholine in 0.1 M potassi-
um phosphate buffer (pH 7.0) at 25 °C, in the presence of 0.5 mM
5,5′-dithiobis-(2-nitrobenzoic acid) [11]. One unit of activity is defined
as 1 μmol of acetylthiocholine hydrolyzed per minute. The specific ac-
tivity of 99% pure FBS AChE at pH 7.0, 25 °C is 2160 units/mg where
protein concentration is calculated from absorbance at 280 nm. The
same preparation has a specific activity of 3000–3300 units/mg when
activity is assayed at pH 8.0 [9].
2.3. HPLC purification of tetramer organizing peptides
In preparing a sample for HPLC purification of the organizing pep-
tides, the buffer for 14.1 ml of FBS AChE (350 U/ml) was changed
from 50 mM sodium phosphate pH 8.0 containing 50% glycerol to
10 mM ammonium bicarbonate pH 8.1 plus 0.01% sodium azide by
concentrating the sample to 1 ml in a 10-ml, Amicon stirred-cell
(Millipore, Billerica, MA, catalog # 5121) using a YM 30 membrane
(Millipore, catalog #13612) and then diluting it to 9 ml. This was re-
peated 3-times. Finally, the sample was concentrated to 1.4 ml
(A280=2.4 with a measured activity of 2800 U/ml). Assuming 100%
purity and using an A280 value of 1.1 for 1 mg/ml FBS AChE, a protein
concentration of 2.2 mg/ml could be calculated for this preparation.
The polyproline peptides were released from the FBS AChE prepara-
tion (1.4 ml at 1.3 mg AChE/ml in 10 mM ammonium bicarbonate
pH 8.1 plus 0.01% azide) by heating the AChE in a boiling water bath
for 5 min. The boiled AChE was acidified to pH 2 with trifluoroacetic
acid, filtered through a 0.2 μm syringe filter, and injected onto a Zorbax
300 SB C-18 reverse-phase column (Agilent Technologies, Santa Clara,
CA, U.S.A.) attached to a Waters 625 HPLC system (Milford, MA,
U.S.A). The HPLC was operated at room temperature (22 °C) at a flow
rate of 0.5 ml/min. Buffer Awas 0.1% trifluoroacetic acid inwater; buffer
B was 0.09% trifluoroacetic acid in acetonitrile. Peptides were eluted
with a gradient of 0–60% buffer B in 60 min. The absorbance was mon-
itored at 210 nm. The HPLC eluent was collected into 1 min fractions
(0.5 ml each). Each fraction was concentrated to approximately 50 μl
in a vacuum centrifuge (Savant SpeedVac), and saved at 4 °C for mass
spectrometry analysis.
2.4. Filtration to separate tetramer organizing peptides from FBS AChE
In preparing a sample for direct application of the organizingpeptides
onto theMALDI target plate or for Orbitrap analysis, the buffer for 1.5 ml
of FBS AChE (2070 U/ml) was replaced with water using an Amicon
stirred cell as described above (process was repeated 4-times). The
sample volume was reduced to 0.4 ml. The sample was boiled for
5 min to release the polyproline peptides, and then filtered through a
Microcon ultracel YM 10 spin filter (MW cutoff 10,000 Da) to separate
the released peptides from residual protein. The volume of the filtrate
was concentrated to 0.1 ml making the final concentration of peptides
equivalent to that expected from a 25 mg/ml sample of AChE.
2.5. MALDI–TOF–TOF mass spectrometry
All MALDI–TOF–TOF experiments were performed on an Applied
Biosystems MALDI–TOF–TOF 4800 mass spectrometer equipped with
a 355 nm Nd–YAG laser (Applied Biosystems, Framingham, MA). The
samples (0.5 μl) were spotted on a MALDI target plate (Opti-TOF 384
well Insert from Applied Biosystems), air-dried and overlaid with
0.5 μl of α-cyano-4-hydroxy cinnamic acid matrix. Mass spectra were
acquired in positive ion reflectormode, under delayed extraction condi-
tions (500 ns), using an acceleration voltage of 20 kV, with laser inten-
sity of 4000–6000 V, a mass range of 1000–4000 Da, a detector voltage
multiplier of 0.75, with lowmass gate on and lowmass gate offset equal
to zero. Mass spectra shown are the average of 500 laser shots collected
from randomly selected locations on the target spot (50 pulses per loca-
tion). Selected ions were fragmented by collision-induced dissociation,
using a 1 kVmethod,with air as the collision gas at 2×10−6 Torr, a pre-
cursor mass window of ±1 Da, metastable suppression on, a detector
voltage multiplier of 0.95, using factory calculated delayed extraction
values (DE1=370 ns, DE2=37,271 ns), and with timed ion selector
activated. The identity of the fragments in the MSMS spectra were
assigned manually using the Data Explorer software (version 4.9 from
Applied Biosystems) with the aid of the Proteomics Toolkit (http://db.
systemsbiology.net) and the MS Product algorithm in Protein Prospec-
tor v 5.9.4 from the University of California, San Francisco mass spec-
trometry facility (prospector.ucsf.edu/ prospector/mshome.htm).
2.6. LC/MSMS Orbitrap mass spectrometry
The sample was prepared for the Orbitrap by diluting a 3.6 μl ali-
quot of the Microcon YM 10 filtrate from boiled FBS AChE (made as
described above: 25 mg/ml in water) with 6.4 μl of 0.1% formic acid
to make a 116 μM solution of peptides.
LC/MSMS analysis was performed on an LTQ Orbitrap quadrupole
mass spectrometer (Thermo Scientific a part of Thermo Fisher Scientific,
Rockland, IL) using electrospray ionization. Five microliters of the sam-
plewere loaded onto a C18 reverse phase trap column (CapTrapPeptide
from Michrom BioResources, Auburn, CA, catalog # TRI/25109/32) and
washedwith 2% acetonitrile/water plus 0.1% formic acid, on an Eksigent
nanoLC 2D HPLC system. Then, the peptides were transferred to a C18
reverse phase separation column (Picofrit BioBasics C-18 from New
Objective, Woburn, MA, catalog # PF 7515-100H052) and eluted with
a 45 min linear gradient starting with 98% solvent A (2% acetonitrile/
water plus 0.1% formic acid) and 2% solvent B (98% acetonitrile/water
plus 0.1% formic acid) and ending with 35% solvent A and 65% solvent
B. The flow ratewas 250 nl/min and the effluent was electrosprayed di-
rectly into the mass spectrometer. Data were collected in a data depen-
dent manner with each cycle consisting of one high-resolution mass
spectrum (over a 300 to 2000 Da mass range) taken with the Orbitrap
and five MSMS fragmentation spectra taken with the LTQ ion trap.
Collision-induced dissociation was used for fragmentation with helium
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as the collision gas (at 1×10−3 Torr) and a normalized collision energy
of 35 (or about 35% of the maximum collision energy of 5 V). The acti-
vation time was 30 ms, and the activation Q was 0.25. Parent ions of
any charge state with a minimum signal intensity of 50,000 cps were
accepted for fragmentation. After two data collections for a given
mass were completed, that mass was excluded from further analysis
for 60 s. Fragmentation spectra were analyzed manually using the
Qual Browser feature of Xcalibur software (v 4.9 from Thermo
Scientific).
3. Results
3.1. MS analysis
The peptides released from heat-denatured FBS AChE are proline-
rich. We found that freezing in the absence of glycerol also caused re-
lease of proline-rich peptides from FBS AChE. Fig. 1 is a MALDI TOF
mass spectrum showing the masses of the released peptides. They
range in mass from 1037 to 2764 Da. The three most prominent peaks
(1949.9, 1971.9 and 1993.9 Da) represent the same peptide in 1) the
protonated form, 2) the single-sodium adduct form and 3) the double-
sodium adduct form, respectively. All major peptides from this sample
were subjected to collision-induced fragmentation in the MALDI mass
spectrometer. Qualitatively, the same information was obtained from
the samples before and after HPLC purification, however better quality
fragmentation spectra were obtained from the HPLC purified peptides.
For the peptides with themore intense signals, collision-induced dis-
sociation in either the MALDI or Orbitrap mass spectrometers provided
enough fragmentation information to determine their amino acid se-
quences. These peptides are listed in Table 1. Fragmentation series of
the y-, b- and a-ion types were observed. In most cases, the peptides ob-
servedwith theMALDImass spectrometerwere in complexwith a single
sodium atom (sodium replacing the added protonwhichmakes the pep-
tide positively charged) while those in the Orbitrap were sodium free.
Five different families of peptides are shown in Table 1, all of which
contain extended stretches of proline residues. Family 1 has nine pep-
tides composed solely of proline (from 13 to 25 residues long). Families
2, 3, and 4 contain a non-proline residue at the N-terminus (alanine,
leucine/ isoleucine/hydroxyproline, or glutamine/lysine), while Family
5 has serine at the C-terminus. The parent ions in families 1 and 2
include peptides with different numbers of prolines. Different length
peptides could arise either naturally via exopeptidase action on the
tetramerization peptidewhile it was attached to AChE in the circulation
or via in-source fragmentation of the liberated peptide during
introduction into the mass spectrometer. We have seen in-source frag-
mentation of model polyprolines, in the MALDI mass spectrometer, at
laser energies of 4000–6000 V, such as were used in the current exper-
iments (LMS unpublished observations). However, the electrospray
ionization energies employed to introduce samples into the Orbitrap
are substantially lower making it less likely that in-source fragmenta-
tion is responsible for the variation in parent ion length seen in the
Orbitrap experiments. Thus, it is likely that both possibilities for short-
ening the peptide are operative.
Examples of MSMS spectra for these peptides are given in Figs. 2, 3
and 4. The principal ion series detected were a-, b- and y-ion series.
The a-series were seen exclusively from peptides in complex with so-
dium. The b-ion series were found exclusively in the Orbitrap data.
There were also major peaks at high mass due to sodium-promoted
C-terminal fragmentation. There were stretches of minor peaks corre-
sponding to series of prolines that were not associated with a-, b- or
y-ion series. Finally, it was common to find a series of fragments asso-
ciated with internal fragmentation at proline. Internal fragmentation
at the relatively labile proline linkage is a well established phenome-
non in mass spectrometry and would be expected under the current
circumstances where many prolines are present in the peptides.
Most of the unannotated peaks in the MSMS spectra could be
accounted for by one-or-another of these types of fragmentation.
3.2. MSMS fragmentation analysis, the first example
Fig. 2 shows MSMS data for the 1885.0 Da peptide, taken with the
MALDI mass spectrometer. The parent ion mass is consistent with the
presence of 19 prolines plus a sodium atom. Presence of the sodium
Fig. 1.MALDI mass spectrum of the peptides released from FBS AChE by boiling. Peptides
were separated from bulk protein by filtration through a YM10 membrane (10,000 MW
cutoff). The right-hand y-axis indicates the signal intensity in counts-per-second.
Table 1
Summary of the peptides released from FBS AChE. Peptides were extracted from serum
acetylcholinesterase by simple denaturation and identified by mass spectrometry. Se-
quences were assigned by manual evaluation of the mass spectral fragmentation
patterns.
Sequencea # of
residues
Series
typeb
Instrument Mass,
Da
Family 1
(PPP)PP PPPPP P(PP) 13 y-, b-ion Orbitrap 1280.7
(PPPP)P PPPPP PPPP 14 b-ion Orbitrap 1377.7
(PPPPP P) PPPP PPP(PP) 15 y-ion Orbitrap 1474.8
(PPPPP PP)PPP (PP)P(PP P) 16 y-, b-, a-ion Orbitrap 1571.0
(PPPPP) PPPPP PPPPP PP 17 b-, a-ion Orbitrap 1668.9
PPPPP PPPPP PPP(PP PPP) Na+ 18 y-, b-, a-ion MALDI 1788.3
PPPPP PPPPP PP(PPP PPPP) Na+ 19 y-, b-, a-ion MALDI 1885.0
(PP)PPP P(PP)PP P(PPPP PPPPP
PPPP)
24 y-ion MALDI 2348.3
(PP)PPP PPPPP PPPPP
(PPPPP PPPPP)
25 y-ion MALDI 2445.2
Family 2
(APPP)P PPPPP PP(PP) 14 y-, b-ion Orbitrap 1351.7
(APPPP P)PPPP (PP)(PPP P) 16 y-ion Orbitrap 1545.8
Family 3
(L/I/Hyp PPPP) PPPPP P(PPP)(PP) 16 y-ion Orbitrap 1587.9
Family 4
PPPQ/KP PPPPP P(PPPP PP) Na+ 17 y-, b-ion MALDI
Orbitrap
1721.9
Family 5
PPPPP PPPPP PP(PPP PPPPP S) Na+ 21 y-, a-ion MALDI 2069.1
a Peptide sequences are written with the N-terminus on the left and the C-terminus
on the right. Residues enclosed in brackets indicate that separate signals for the masses
of each residue were not resolved in the mass spectrum. However, masses of the brack-
eted fragments exactly fit the indicated sequence. Leucine, isoleucine, and hydroxypro-
line (L/I/Hyp) cannot be distinguished because they have the same mass. Glutamine
and lysine (Q/K) cannot be distinguished because they have the same mass.
b The “Series type” column lists the major fragment series observed in the MSMS
spectrum of each peptide. Peptide sequences to the left of each series type indicate
the specific sequence associated with each type.
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atom is confirmed by the appearance of a mass at 23 Da. The y-axis
maximum has been lowered to emphasize the weaker signals. An
array of peaks that defines a y-ion series and another array that define
an a-ion series are annotated. The sodium atom remained associated
with the N-terminal fragment in the a-ion series and with the
C-terminal fragment in the y-ion series. There is also an array of peaks
1 Da larger than the a-ion series (an a+1 ion series) which were not
annotated in order to avoid over-crowding of the spectrum. Seven res-
idues in the low mass portion of the y-series gave no signals. However,
the y7 mass (720.4 Da) is equal to the mass of a C-terminal proline
(116 Da) plus the mass of 6 dehydro-prolines (6×97.05 Da), plus the
mass of sodium (23 Da), and minus the mass of the proton displaced
by the sodium (1 Da). There were no individual signals for the last
two residues in the high mass portion of the a-ion series. However,
the delta mass of 240 Da was equal to the C-terminal mass of a proline
(143 Da) plus the dehydro-masse of proline (97 Da).
The five most prominent peaks in the high mass region can be as-
cribed to sodium-promoted fragmentation at the C-terminus. Sodium-
promoted fragmentation will be described in more detail in the section
entitled “Sodium-promoted fragmentation”. The peaks from the
sodium-promoted fragmentation are truncated in Fig. 2. Their full
height is 10-fold greater than most of the ions in the low mass region.
The sodium-promoted fragment ions are marked with an asterisk (*).
They include 1) the most intense signal, at 1788.1 Da, that is consistent
with a neutral loss of the dehydro-mass for the C-terminal proline
(97 Da); 2) an intense signal at 1691.0 Da that is consistent with loss
of a second proline (97 Da) from the 1788.1 Da mass; 3) a mass at
1840.9 Da that is consistent with the loss of CO2 (44 Da) from the par-
ent ion; 4) amass at 1772.1 Da that is 16 Da smaller than the 1788.1 Da
mass; and 5) a mass at 1744.1 Da which is consistent with loss of CO2
from the 1788.1 Da mass. The 1788.1 and 1691.0 Da peaks overlap
with the y17 and y18 ions from the y-ion series, however the intensities
of these peaks are much higher than that for the rest of the y-ion series
indicating that there is a second source for ions at these positions. The
masses at 1744.1, 1772.1 and 1841.8 Da do not correspond to any se-
quence ion. Identification and assignment of these fragments was
made by consulting the literature and from unpublished observations
on fragmentation of pure polyproline.
Finally, there are small, but distinct signals for the immonium ion
of proline at 70 Da [12] and for a characteristic proline fragment at
126 Da [listed on the Protein Prospector website; http://prospector.
ucsf.edu] (refer to Fig. 2). We suggest that this 19 residue peptide is
a fragment of the 25 residue polyproline peptide that is also listed
in Table 1.
3.3. Sodium-promoted fragmentation
A sodium ion (Na+) can form a complex with peptides in which
the Na+ displaces a proton to create what is referred to as an alkali
metal cationized peptide. The most prominent ion that results from
fragmentation of cationized peptides in the mass spectrometer is
due to the loss of the dehydro-mass of the C-terminal residue. This
yields a new peptide that is one amino acid shorter than the original
peptide [13–17]. The mechanism for this fragmentation “involves the
transfer of the hydroxyl group from the C-terminus of the peptide to
Fig. 2. MALDI MSMS spectrum of the 1885.0 Da, 19-proline peptide (PPP)PP PPPPP
PPPPP PPPP Na+ that was isolated from boiled FBS AChE by HPLC. Amino acid se-
quences are marked to show the y-ion series and a-ion series. The left-hand y-axis
shows the signal intensity as a percentage of the most intense peak. The maximum
value has been set to 40% to accentuate the minor peaks. Consequently, the most in-
tense peaks (those at high mass) have been truncated. The right-hand y-axis indicates
the signal intensity in counts-per-second. Ions from sodium-promoted fragmentation
are identified by an asterisk (*). The immonium ion of proline is at 70 Da and a charac-
teristic ion for proline is at 126 Da. The mass at 23 Da is sodium.
Fig. 3. MALDI MSMS spectrum of the 1721.9 Da peptide PPPQP PPPPP PPPPP PP Na+
isolated from boiled FBS AChE by HPLC. The right-hand y-axis indicates the signal in-
tensity in counts-per-second. Ions from sodium-promoted fragmentation are identi-
fied by an asterisk (*). The immonium ion of proline is at 70 Da. The sodium atom is
at 23 Da.
Fig. 4. Orbitrap MSMS spectrum of peptide PPPPP PPPPP PPP isolated from boiled FBS
AChE by HPLC. The doubly-charged parent ion has a mass of 640.85 m/z. Amino acid
sequences are marked to show singly-charged y-ion series, singly-charge b-ion series,
a doubly-charged y-ion, and a doubly-charged b-ion series. The y-axis shows the signal
intensity relative to the most intense peak in the spectrum.
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the adjacent amino acid and subsequent loss of the residue mass of
the C-terminal amino acid [97 Da for proline] leading ultimately to
the production of a new alkali cationized peptide lacking the original
C-terminal residue” [17]. Additional fragmentation can occur for the
newly formed alkali cationized peptide resulting in ions which are
two and even three amino acids shorter than the original peptide.
The signal intensity of the ion from the second fragmentation can
be comparable to that from the first, but the signal intensity for the
ion from third fragmentation is generally much smaller [18].
In Fig. 2, the first cycle of sodium-promoted fragmentation is con-
sistent with formation of the intense, 1788.1 Da fragment. A second
cycle of sodium-promoted fragmentation would be consistent with
the intense signal at 1691.0 Da. However, assigning subsequent
fragments to sodium-promoted fragmentation is complicated by
overlapping fragments from the weaker, y-ion series. The complica-
tion arises from two facts. First, the delta mass for loss of the
N-terminal residue from a y-ion series (the highmass end of the spec-
trum) is equal to the dehydro-mass of the residue. The delta mass for
sodium-promoted fragmentation of the C-terminal residue is also
equal to the dehydro-mass. Second, the peptides in this study have
proline residues at both the C-terminus and the N-terminus (refer to
Table 1). Consequently, the delta mass for release of the N-terminal
residue for a y-ion series is the same as the delta mass for release of
the C-terminal residue by sodium-promoted fragmentation. Discrimi-
nation between the two pathways relies on the relative intensities of
the fragments. The principal contribution to high intensity signals
can be ascribed to sodium-promoted fragmentation, with minor con-
tribution coming from y-ion fragments when the masses from the
two pathways overlap.
Additional sodium-promoted fragmentation can result in a prom-
inent loss of 44 Da from the parent ion (probably due to loss of CO2)
[15]. A prominent mass at 1840.9 Da in Fig. 2 corresponds to this frag-
mentation. Another loss of 44 Da is associated with the 1788.1 Da
fragment. Finally, for polyproline peptides, a novel mass, 113 Da
smaller than the parent ion (equal to 97 Da plus 16) is typically
seen in sodium-promoted fragmentation spectra (L.M. Schopfer,
unpublished observations). The 1772.1 Da fragment in Fig. 2 corre-
sponds to this ion.
3.4. MSMS fragmentation, additional examples
Fig. 3 shows MSMS data for the 1721.9 Da peptide, taken with the
MALDI mass spectrometer. The parent ion mass is consistent with the
presence of 16 prolines plus a glutamine (or lysine), and a sodium
atom. Presence of the sodium atom is confirmed by the mass at
23 Da. Fragmentation is again dominated by sodium ion promoted
processes. Masses at 1677.7, 1624.9, 1608.9, 1581.0 and 1527.9 Da
are consistent with 1) loss of CO2 from the parent ion, 2) loss of a pro-
line from the C-terminus, 3) loss of 16 Da from the 1624.9 Da ion,
4) loss of a CO2 from the 1624.9 Da mass, and 5) loss of a proline
from the 1624.9 Da mass, respectively. An extensive y-ion series
(that includes 13 consecutive prolines) can be extracted from the
minor signals. Once again, the y-ion series overlaps the cation pro-
moted fragments. A sequence interval of 128 Da for the difference be-
tween 1302.8 and 1430.8 Da corresponds to either a lysine or a
glutamine residue. Y-ion and b-ion sequences from two analogous
peptides (obtained with the Orbitrap mass spectrometer, see
Table 1) indicated the presence of a glutamine/lysine residue on the
N-terminus of a long string of prolines confirming the presence of
this non-proline residue in the sequence (data not shown). We have
assigned the residue to glutamine on the basis of BLAST search results
(see the section entitled “BLAST search”).
The high intensity of the 1302.8 Da peak is also consistent with
the presence of a non-proline residue at this position. The
1302.8 Da mass arises from cleavage on the N-terminal side of pro-
line. The well known “Proline Effect” [19] is renowned for enhancing
the intensity of fragments on the N-terminal side of proline. Finally, a
distinct peak for the proline immonium ion was observed at 70 Da
[12].
Fig. 4 shows MSMS data for a doubly-charged peptide
([M+2H]+2=640.85 Da) taken with an LTQ Orbitrap mass spec-
trometer. The parent ion mass is consistent with the presence of 13
prolines. Singly-charged peaks for both y-ion and b-ion series are an-
notated. In addition, there are prominent peaks for doubly-charged
b-ions and a y-ion. All of these ions are consistent with a peptide
containing only prolines. It is noteworthy that there are strong signals
for both a singly-charged y-ion series and a singly-charged b-ion se-
ries, and that there is no evidence for fragmentation favoring the
loss of two prolines at a time, for either series. This can be compared
to studies by Unnithan et al. on Pron-NH2 peptides (n=4–10) who
observed that “even numbers of Pro residues were lost from the
N-terminal end of the peptide” to form a singly-charged y-ion series.
B-ions were not detected [20]. Paired loss of prolines from proline-
rich regions was supported by Wang et al. in studies of the proline-
rich, 79-residue polypeptide, prophenin 1 [21]. A possible explana-
tion for the difference in fragmentation patterns is that a much higher
gas pressure was used in the fragmentation chamber of the Orbitrap
(helium at 1×10−3 Torr) compared to that used by Unnithan et al.
in the Brucker Esquire 3000 plus quadrupole ion trap (helium at
3×10−5 Torr).
3.5. BLAST search on the proline-rich peptides
A total of fourteen proline-rich peptides were identified from FBS
AChE (Table 1). All of these are suitable candidates for tetramer-
organizing peptides. These peptides could be divided into five fami-
lies. The origin of these peptides is unclear. A logical assumption
would be that they begin as part of another protein. In order to test
this assumption, the longest representative from each family was
submitted for a BLAST (Basic Logical Alignment Search Tool) search
of the NCBInr database (November 2011) using the mammalian tax-
onomy (40674). Matches were found for each family. We had antici-
pated that the necessity for 15 or more prolines in a row would have
imposed a severe limitation on the number of matching candidates.
However, this was not the case. For example, we found 25 separate
proteins that matched the APPPP PPPPP PPPPP P sequence from fam-
ily 2. Attempting to sort through this abundance of candidates for
those that interact specifically with AChE is beyond the scope of the
current study. Therefore, we have selected representative examples
for purposes of discussion, which are shown in Table 2. When possi-
ble, a protein from the Bos taurus taxonomy was chosen for Table 2.
When no candidates appeared in the B. taurus taxonomy, a candidate
from the Homo sapiens taxonomy was used. The proteins listed in
Table 2 should not be assumed to be the actual source of the corre-
sponding peptide found in AChE tetramers. This issue is addressed
in greater detail in the Discussion, Section 4.
Nine of the peptides from Table 1 consisted of only proline resi-
dues (family 1). A Blast search using the 25-residue proline peptide
found seven different proteins that contained a continuous stretch
of 25 prolines. There was no match from the bovine proteome so
“UDP-N-acetyl glucosamine transferase subunit homology domain-
containing protein 1” from the H. sapiens taxonomy was selected for
use in Table 2.
The second family was represented by APPPP PPPPP PPPPP P. There
was some ambiguity in the position of the alanine in the N-terminus
(see Table 1). Consequently, a BLAST search wasmadewith the alanine
at positions 1, 2, 3 and 4 from the N-terminus. All four searches yielded
matches to multiple proteins. With the alanine in the N-terminal posi-
tion (as shown in Table 2) 25 proteins matched the sequence. Five
of these proteins were found in the B. taurus taxonomy (Predicted
R3H domain-containing protein 1; Leiomodin-2; Predicted formin-like
1; Large proline-rich protein BAG6; and Zinc finger homeobox 4).
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Leiomodin-2 was selected for Table 2. Progressively fewer protein
matches were found each time the alanine was moved one position to-
ward the C-terminus. The PPPAP PPPPP PPPPP P peptidematched 6 pro-
teins, only one of which was present in the first set of 25. The APPPP
PPPPP PPPPP P peptide sequence was consistent with a tetramer-
organizing peptide from leiomodin-2 that was reported by Biberoglu
et al. for horse butyrylcholinesterase [22].
The third family was represented by peptide L/I/Hyp PPPPP PPPPP
PPPPP. Though there was some ambiguity in the exact position of the
L/I/Hyp residue (see Table 1), BLAST searches were made only with
the L/I/Hyp residue in the N-terminal position. Leucine (L), isoleucine
(I) and hydroxyproline (Hyp) all have the same nominal mass and
therefore were not distinguished by mass analysis. BLAST searches
were made for both the leucine and isoleucine possibilities. It was
not possible to use hydroxyproline in a BLAST search. When leucine
was used as the N-terminal residue, matches were obtained to 23
proteins, 3 of which were in the B. taurus taxonomy (Protein diapha-
nous homolog 3, DIAPH3; Lysine-specific demethylase 6B; and Zinc
finger protein 318). “Zinc finger protein 318” was used for Table 2.
When isoleucine was used as the N-terminal residue, a match was
obtained for 2 proteins, only one of which (predicted YLP motif-
containing protein 1) was from the B. taurus taxonomy. The L PPPPP
PPPPP PPPPP sequence was consistent with the tetramer-organizing
peptide from lamellipodin that was reported by Li et al. for human
butyrylcholinesterase (PSPPL PPPPP PPPPP PPPPP PPPPP LP) [8] and
confirmed by Biberoglu et al. [22]. Lamellipodin from the H. sapiens
taxonomy was included in Table 2 to draw attention to the possibility
that lamellipodin might be a source for this peptide in bovine as well.
The fourth familywas represented by peptide PPPQ/KP PPPPP PPPPP
PP. In this case, there was no ambiguity regarding the position of the
Q/K residue. Lysine (K) and glutamine (Q) both have the same nominal
mass and therefore precise identification of the correct residue could
not be made from the mass spectrum. A BLAST search using lysine
yielded no matches, whereas a search with glutamine yielded six pro-
teins. “Paternally expressed 10 isoform 3” was the only match from
the bovine proteome. Reversing the sequence to PPPPP PPPPP PPPQP
PP or PPPPP PPPPP PPPKP PP resulted in no BLAST search matches,
supporting the sequence as given in Table 2.
From the fifth family, the last three residues on the C-terminus of
peptide PPPPP PPPPP PPPPP PPPPP S were not resolved (see Table 1).
BLAST searches found a match only when serine was the C-terminal
residue. That search yielded a match to only one protein, zinc finger
homeobox protein 4, which was found in the B. taurus taxonomy,
among others.
In conclusion, the blast search results indicate that peptides from
many proteins could participate in the tetramerization of FBS AChE.
4. Discussion
4.1. Comparison of proline-rich peptides in soluble and
membrane-anchored tetramers
Our study identified polyproline peptides in soluble, tetrameric FBS
AChE. Previously, polyproline peptides have been identified in soluble,
tetrameric human and horse butyrylcholinesterase (BChE) fromplasma
[8,22]. The polyproline peptides in plasma AChE and plasma BChE re-
semble each other but are distinctly different from the proline-rich
attachment domain (PRAD) of ColQ in the collagen tailed AChE in the
neuromuscular junction, and from the PRAD of the proline-rich mem-
brane anchor (PRiMA) in the membrane-anchored AChE of brain
(Table 3). The polyproline peptides in plasma AChE and BChE tetramers
have long strings of prolines up to 25 residues in length, whereas the
proline-rich region of ColQ has 8 proline residues and that of PRiMA
has 14 proline residues. In ColQ and PRiMA, the string of prolines is
interrupted by Leu, LeuPhe, MetPhe or Met. Table 3 shows only one
peptide for FBS AChE; additional peptides are in Table 1.
The differences in amino acid sequence between the tetramer or-
ganizing peptides from soluble AChE, BChE and the proline-rich pep-
tides of ColQ and Prima are shown in Table 3. These differences mean
that the tetramer organizing peptides of soluble cholinesterases are
produced from genes that are distinct from those for ColQ and
PRiMA. Thus, soluble AChE and BChE tetramers in plasma do not
Table 2
Blast search results on the peptides released from FBS AChE.
Family Sequencea Blast resultb Species GI numberd
1 PPPPP PPPPP PPPPP PPPPP PPPPP UDP-N-acetyl glucosamine transferase ALG13 subunit homology
domain-containing protein 1
Homo sapiensc 153791910
2 APPPP PPPPP PPPPP P Leiomodin-2 Bos taurus 157427900
3 LPPPP PPPPP PPPPP Pe
IPPPP PPPPP PPPPP P
LPPPP PPPPP PPPPP P
Zinc finger protein 318;
Predicted YLP motif-containing protein 1
lamellipodin
B. taurus
B. taurus
H. sapiens
194677641
297479917
82581557
4 Q/KPPPP PPPPP PPPPP PP Paternally expressed 10 isoform 3 B. taurus 187761320
5 PPPPP PPPPP PPPPP PPPPP S Zinc finger homeobox protein 4 B. taurus 330340393
a Peptides in this column represent the longest members of each family given in Table 1.
b Data were BLAST searched using the Mammalian taxonomy (40674) in the NCBInr database.
c A matching sequence was not found in the bovine proteome, therefore a corresponding match from the H. sapiens taxonomy was used.
d The GI number is the protein accession number in the NCBI database in PubMed.
e When leucine (L) was used, a match was obtained with the Zinc finger protein 318 of B. taurus and with lamellipodin of H. sapiens. When isoleucine (I) was used, a match was
obtained with the predicted YLP motif-containing protein 1 of B. taurus. Leucine and isoleucine cannot be distinguished on the basis of mass.
Table 3
Comparison of tetramer organizing sequences in soluble and membrane-anchored tet-
ramers of AChE and BChE.
Source Sequence Reference Accession #a
Fetal bovine
serum AChE
PPPPPPPPPPPPPPPPPPPPPPPPP25 This work
Human plasma
BChE
PSPPLPPPPPPPPPPPPPPPPPPPPLP27 [8] gi 82581557
Horse plasma
BChE
PSPPLPPPPPPPPPPPPPPPPPPPPLP27 [8] gi 82581557
Human ColQ LLTPPPPPLFPPPFF15 [26] gi 18105016
Rat ColQ LLMPPPPPLFPPPFF15 [27, 28] gi 9506503
Mouse ColQ LLMPPPPPLFPPPFF15 b gi 122065161
Torpedo ColQ LLTPPPPPMFPPPFF15 [29] gi 543769
Human PRiMA RPPPPLPPPPPPPPPPRLLS20 [4] gi 29788778
Rat PRiMA RPPPPLPPPPPPPPPPRLLS20 b gi 205830448
Mouse PRiMA RPPPPLPPPPPPPPPPRLLS20 [30] gi 29824432
a The NCBI accession numbers are for the proteins from which the proline-rich pep-
tides are derived.
b Mouse ColQ and rat PRiMA sequences were submitted to PubMed without a jour-
nal publication.
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derive from the membrane-bound forms. For human and horse plas-
ma BChE the source of the polyproline peptide appears to be a
number of proteins including lamellipodin [8,22]. In our first report,
we identified lamellipodin as the source of the tetramer organizing
polyproline peptide [8] however subsequent investigations found
that tetramer organizing peptides could be traced to several proteins
[22]. Reasons for the differences in the results are discussed in
Biberoglu et al. [22]. For FBS AChE there also appear to be multiple
sources. Therefore, no single gene encodes for all of the polyproline
peptides identified in either soluble BChE or soluble AChE.
4.2. Noncovalent binding
Thepolyproline peptides are boundnon-covalently to tetrameric FBS
AChE. The peptides were easily released by denaturing the protein in
boiling water, or by freezing the protein in the absence of a cryoprotec-
tant. The interaction of polyproline with the tetramerization domain is
very strong as the tetramer does not dissociate upon dilution down to
nanomolar levels. Released peptides were visualized at 210 nm in
an HPLC chromatogram and by mass spectrometry. However, the
polyproline peptides were not detected on polyacrylamide gels stained
with Coomassie blue or on gels reverse stainedwith imidazole-zinc [23].
4.3. A second gene product is required to make a tetramer
To date AChE and BChE are the only proteins known to require a
polyproline peptide for assembly into tetramers. A search of the
Protein Data Bank showed many tetrameric crystal structures but
none included a polyproline peptide derived from a second gene.
The common motif for tetramer organization is through interactions
of side chains of the 4 subunits. AChE and BChE also have contacts be-
tween subunits but these are not sufficient to stabilize the tetramer.
The cartoon in Fig. 5 indicates the location of a polyproline peptide
in the center of the tetramer. This cartoon is presented to emphasize
the overall organization of the AChE tetramer and to focus attention
on the role of the tetramerization peptide in organizing this structure.
The planar symmetry and large contact area between the polyproline
peptide and the core of the AChE are not intended to realistically rep-
resent the details of the interaction.
Muscle and brain contain not only membrane bound forms of
AChE but also a small amount of soluble tetrameric AChE. It is not
known what type of proline-rich peptide is present in tetrameric
AChE in these tissues. We expect that future studies will identify
additional tetrameric proteins that include a non-covalently bound
polyproline peptide in the tetrameric structure.
4.4. The proline-rich peptides released from FBS AChE contain
up to 25 residues
The crystal structure of the complex between synthetic humanPRAD
and 4 parallel chains representing the tetramerization domain showed
that the coiled 15-residue ColQ PRAD peptide (LLTPP PPPLF PPPFF) has
the same length as the helical 40-residue tetramerization domain of
AChE [5]. The crystal structure of full-length tetrameric AChE complexed
with a proline-rich peptide is not yet available. However, information
from the crystal structure of synthetic peptides allowed Dvir et al. to
produce amodel of theAChE tetramer linked to the full length ColQ pro-
tein. Fig. 6 (adapted from Dvir et al.) shows that the ColQ protein tra-
verses the entire AChE tetramer. The N-terminal region of ColQ
interacts with the AChE C-terminal tetramerization domain in an anti-
parallel head-to-tail configuration, passes through the center of the
AChE tetramer and extends out the other side. This configuration will
accommodate all sizes of polyproline peptides observed in our study, in-
cluding the25-residue polyprolinepeptide. A complete symmetry of the
four subunit positions would not necessarily be expected since the
tetramerization domains must accommodate to the helical structure of
the polyproline.
4.5. Requirement for protease activity
Protease activity is not involved in the production of themembrane-
anchored forms of AChE. In contrast, the polyproline peptides in plasma
Fig. 5. Four identical subunits of fetal bovine serum AChE (accession number gi 108493
and gi 115497516) are linked by interactions with a polyproline peptide in the center
of the tetramer. Dimers of AChE are formed by interchain disulfide bonds at Cysteine
580. The close contact between the globular subunits is intended to show that interac-
tions between subunits contribute to the stability of the tetramer. Each AChE subunit
contains 583 amino acids. The MW of the glycosylated tetramer is 340 kDa.
Fig. 6.Model of the AChE tetramer in the presence of the full-length ColQ protein. AChE
monomers are displayed as globular units with their tryptophan-rich, C-terminal,
amphiphilic α-helices protruding out from the top of each unit. The ColQ protein, or
alternatively the tetramer organizing polyproline peptide (yellow), projects through
the middle of the AChE tetramer complex. The N-terminus of ColQ interacts with the
C-terminal tetramerization domain of AChE (at the top) and extends as a single
chain through the bottom of the complex. Figure reproduced from Ref. [5].
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AChE and plasma BChE derive from large precursor proteins that must
undergo proteolysis to yield the proline-rich peptides. It is unknown
whether the entire precursor protein is initially assembled together
with the AChE tetramer followed by proteolysis, or whether proline-
rich peptides are released from the precursor proteins before assembly
with AChE subunits to yield AChE tetramers. The polyproline peptides
released fromFBSAChE range in size from1280 to 2445 Da correspond-
ing to 13 to 25 amino acid residues. The various sizes could originate
from protease activity in plasma. Mass spectrometry analysis of the
low molecular weight plasma proteome has demonstrated that prote-
ases including aminopeptidase and carboxypeptidase convert large
proteins to overlapping series of related peptides [24].
4.6. Assembly of the AChE tetramer
The presence of a set of different polyproline peptides extracted
from the cores of soluble AChE tetramers raises a number of questions.
First, could the variety of tetramer-organizing peptides reflect AChE ex-
pression from different tissues? Second, unlikemembrane-bound AChE
tetramers (which employ dedicated proteins that carry proline-rich tet-
ramer organizing domains) the tetramer organizing peptides for solu-
ble AChE appear to come from proteins designed for other purposes.
How do these precursor proteins release the polyproline peptides for
use in AChE? Is the polyproline peptide added to the oligomers prior
to secretion or do these associations occur spontaneously in the blood-
stream? Is there any evidence for the presence of putative precursor
proteins in the endoplasmic reticulum and/or Golgi where interaction
with developing AChE might be expected to occur? Third, since the
AChE used in our experiments came from pooled serum, could the di-
versity in tetramer-organizing peptides that was observed represent
variations between individuals?
Question 1. The origin of soluble AChE in fetal bovine serum is
unknown. However, it is firmly established that soluble butyryl-
cholinesterase (BChE) in human serum originates in the liver [25]. It is
widely accepted that the origin of mammalian serum cholinesterases,
in general, is the liver. Though fetal bovine could differ, it would be un-
expected to find serum AChE coming from tissues other than the liver.
Question 2. All of the bovine proteins that were found to match the
tetramerization peptides were examined in detail with the goal of de-
termining a mechanism by which the peptide could become associated
with AChE. Their sequences were obtained from the NCBInr Protein re-
source. Their functions, subcellular locations, and tissue distributions
were obtained from UniProtKB protein knowledgebase.
In all, 11 bovine and 1 human protein(s), associated with the 5
peptide families, were examined. The proline-rich sequences from
families 2, 3 and 5 are all located deep within the protein structure
(97 to 1556 residues from the nearest terminus).
Nuclear proteins included: 1) zinc finger protein 318 (gi 194677641)
an endocrine regulator protein expressed in endocrine tissue (containing
a family 3 peptide), 2) lysine-specific demethylase 6B (gi 359076756) a
histone demethylasewith no specific tissue location (containing a family
3 peptide), 3) YLPmotif-containing protein 1 (gi 297479917) involved in
reduction of telomerase activity (containing a family 3 peptide), 4) zinc
finger homeobox protein 4 (gi 296480588) a transcription regulator in-
volved in neural andmuscular differentiation expressed in brain, skeletal
muscle, liver and stomach (containing both a peptide from family 2 and a
peptide from family 5; different peptides), 5) R3H domain-containing
protein 1 (gi 194664704) a nucleic acid binding protein (containing a
family 2 peptide), and 6) myb-related p42POP (gi 359075807) a tran-
scriptional repressor and DNA binding protein (containing a family 2
peptide).
Cytoplasmic proteins (all interacting with the cytoskeleton) included:
7) leiomodin-2 (gi 157427900) an actin and tropomyosin binding
protein found in heart and skeletal muscle (containing a family 2
peptide), 8) protein diaphanous homolog 3, DIAPH3 (gi 296481927) a
profilin and Rho binding protein that promotes actin polymerization
with no tissue specificity (containing a family 3 peptide), and 9)
formin-like 1 (gi 297487196) a regulator of cell morphology and cyto-
skeletal organization that binds to actin and Rho (containing a family
2 peptide).
Two of the remaining three proteinmatches (to families 1 and 2) are
more encouraging in that they are associated with the endoplasmic re-
ticulum and therefore could theoretically come into contact with AChE
as it is being synthesized. UDP-N-acetylglucosamine transferase subunit
ALG13 homology domain-containing protein 1 (gi 153791910) is in-
volved with protein N-glycosylation in the endoplasmic reticulum. It
contains the peptide from family 1. No proteins from the bovine taxon-
omy were matched to the family 1 peptide, therefore this protein from
the human taxonomy has been taken as a credible substitute. The un-
fortunate feature of this protein is that the tetramerization peptide is
located 192 residues from the C-terminus, and further from the
N-terminus. The large proline-rich protein BAG6 (gi 161621275) is a
chaperone associated with insertion of tail-anchored proteins into the
endoplasmic reticulum. It contains a family 2 peptide. Like the previous
candidate, the tetramerization peptide is located well from either ter-
minus (464 residues from the C-terminus). It should be noted that
both of these proteins are associated with the cytosolic, not the luminal
face of the endoplasmic reticulum. Their topology presents a problem
for interactions with AChE.
The most appealing candidate of the 12 is mesoderm-specific
transcript homology protein (MEST) that is also referred to as pater-
nally expressed 10 isoform 3 (gi 187761320) (to family 4). The
tetramerization peptide is ideally suited for association with fetal bo-
vine AChE in that it is located 5 residues from the C-terminus. One can
easily envision the proline helix providing an anchor around which
four AChE monomers could cluster. Once formed, the mature AChE
tetramer could be released by proteolysis of the MEST C-terminus. A
similar mechanismwith other proteins similar to MEST could account
for the other tetramerization peptides isolated from soluble AChE tet-
ramers. The major drawback for this candidate is that it is found in
the nucleus and cytoplasm.
Question 3. Because the AChE used in these experiments came from
multiple animals, the possibility that the different polyproline pep-
tides arose from variations between individual animals cannot be
excluded.
More detailed investigation of these issues is a matter for future
studies.
5. Conclusion
Soluble, tetrameric AChE molecules in plasma contain a polyproline
peptide in their quaternary structure. Five types of polyproline peptide
have been identified. These polyproline peptides are bound to the
C-terminal tetramerization domainwhere they organize four AChE sub-
units into a tetramer. No single protein precursor is the source of these
polyproline peptides.
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